1. | soccerbooters | |
2. | joeholidaybuys | |
3. | djbenmacias | |
4. | candiskingdom | |
5. | bugbeas499315 |
1. | soccerbooters | |
2. | joeholidaybuys | |
3. | djbenmacias | |
4. | candiskingdom | |
5. | bugbeas499315 |
1. | toonses85 02/14/2018 end at low of day, not good |
2. | feruizdeluna 07/30/2018 Beats EPS loss estimates by $0.01. Misses on revenues. |
3. | joeholidaybuys 06/25/2018 Lexicon Pharmaceuticals Announces Positive 52-Week Results From Sotagliflozin inTandem1 Study Presented at ADA 2018 and Published in Diabetes Care |
4. | soccerbooters 05/04/2018 new XERMELO data from the Phase 3 TELESTAR study in Clinical Therapeutics |
5. | djbenmacias 03/29/2018 Lexicon Pharmaceuticals Announces EMA Acceptance of Marketing Authorization Application (MAA) for Sotagliflozin to Treat Adults With Type 1 Diabetes |
6. | candiskingdom 02/26/2018 Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides a Business Update |
7. | soccerbooters 02/14/2018 8.09 now {Image} |
8. | candiskingdom 02/14/2018 Scared to hold to be honest |
9. | bugbeas499315 02/14/2018 JPMorgan cuts to underweight, $10PT |